Indeed, using a murine model, these authors showed that BCR::ABL1 is a negative regulator of CD44 necessary for cell adhesion between CML stem cells and bone marrow endothelium, thus causing a decrease in cell adhesion and enhancing CML stem cell proliferation [11]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.